Publications

Search our bibliography using the filters on the right-hand side.

Displaying 251 through 300 of 372 publications.

Vandenberghe F, Choong E, Saigi-Morgui N, Quteineh L, Ambresin AE, von Gunten A, Conus P, Eap CB. Clinical study on psychotropic drug induced weight gain and other metabolic complications in a Swiss psychiatric population. Poster presented at the 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012; 21(Suppl 3):456. doi: 10.1002

Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Pariente A, Scotti L, Sturkenboom M, Perez-Gutthann S. Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf. 2011 Dec 1;20(12):1225-36.

Kilpatrick RD, Danese MD, Belozeroff V, Smirnakis K, Goodman WG, Rothman KJ. The association of vitamin d use with hypercalcemia and hyperphosphatemia in hemodialysis patients: a case–crossover study. Pharmacoepidemiol Drug Saf. 2011 Sep 1;20(9):914-21.

Kaye JA, Castellsague J, Bui CL, Calingaert B, McQuay L, Riera Guardia N, Saltus CW, Quinlan S, Holick CN, Wahl PM, Rothman KJ, Wallander MA, Perez-Gutthann S. Case screening and validation in a population-based study of antimicrobial use and acute liver injury. Presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 14, 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug 12; 20(S1):S5-6. doi: 10.1002/pds.2206

Lanes SF, Rothman KJ. Back to the future: time loops in defining study populations. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S311.

Castellsague J, Pisa F, Rosolen V, Riera-Guardia N, Giangreco M, Clagnan E, Tosolini F, Zanier L, Barbone F, Perez-Gutthann S. Use of nimesulide, other nsaids and the risk of upper gastrointestinal complications in Friuli Venezia Giulia, Italy. Analysis of cases with codes with high positive predictive value. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S178.

Mikkelsen EM, Riis AH, Hatch EE, Rothman KJ, Wise LA, Sorensen HT. Use of nsaids and other mild analgesics and time to pregnancy. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S55.

Huybrechts KF, Seeger JD, Glynn R, Rothman KJ, Avorn J, Lii J, Schneeweiss S. Accounting for regional variations in medical practice in comparative effectiveness studies. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(Suppl. 1):S325.

Yong M, Schenfeld J, Creamer K, Shi Y, Aras G, Anthony MS. External comparator data for the observational post-marketing safety surveillance registry of enbrel® (etanercept) for the treatment of psoriasis – a single-arm registry study. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S228.

Johannes C, Andrews E, McQuay L, Frohlich M, Sims R. Incidence of cerebrovascular accidents in men with prostate cancer. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 18, 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S271-2.

Rubino A, Wallander MA, Callreus T, Saddier P, Ritchey ME, Perez-Gutthann S. Drug utilization studies and risk management plans: a missing link. Poster presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug 1; 20(Suppl. 1):S269.

Pisa F, Drigo D, Riera-Guardia N, Castellsague J, Rosolen V, Clagnan E, Tosolini F, Zanier L, Perez-Gutthann S, Barbone F. Validation of primary and secondary ICD-9-cm codes for upper gastrointestinal complications in Friuli Venezia Giulia, Italy. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 1, 2011. [abstract] Pharmacoepidemiol Drug Saf. 20(Suppl. 1):S172.

Wyss R, Stedman MR, Brookhart MA, Rothman KJ, Glynn R, Poole C, Seeger JD, Sturmer T. Balance of controlled and uncontrolled covariates as a function of propensity score variable selection methods: a simulation study. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S350.

Midkiff KD, Harris D, Gilsenan AW, Wu Y, Andrews EB. Drug safety studies using cancer registry data: confluence of elements impacting the interview response rate. Poster presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 14, 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug 1; 20(Suppl. 1):S231. doi: 10.1002/pds.2206

López-León S, Fortuny J, Plana E, Zhu Y, Rivero E. The pattern of use of anti-depressant drugs in a pediatric population in a US managed care population. Poster presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(Suppl 1):S101.

López-León S, Fortuny J, Plana E, Zhu Y, Rivero E. Adherence to antidepressant treatment among pediatric population in a US managed care population. Poster presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(Suppl 1):S316.

Patrick AR, Schneeweiss S, Brookhart MA, Glynn RJ, Rothman KJ, Avorn J, Sturmer T. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf. 2011 Jun 1;20(6):551-9.

Mines D, Gu Y, Kou TD, Cooper GS. Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):111-8. doi: 10.1002/pds.2057

Johannes CB, Varas-Lorenzo C, McQuay L, Midkiff KD, Fife D. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study. Pharmacoepidemiol Drug Saf. 2010 Sep 1;19(9):881-8.

Riera Guardia N, Castellsague J, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F. The SOS Project: nonsteroidal anti-inflammatory drugs and upper gastrointestinal complications: meta-analysis of epidemiological studies. Poster presented at the 26th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, UK. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug 24; 19(Suppl 1):S314.

Arana A, Wentworth CE, Rivero E, Plana E, Conde E. Lymphoma among patients with atopic dermatitis treated with topical corticosteroids (TCS) and/or topical calcineurin inhibitors (TCIs). Poster presented at the 26th International Conference on Pharmacoepidemiology; August 2010. Brighton, England. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(S1):S12.

Gilsenan A, Andrews E, Hollis KA. Characterization of current risk evaluation and mitigation strategies. Poster presented at the 26th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(S1):S100. doi: 10.1002/pds.2019

Tennis P, Rothman KJ, Bohn R, Tan H, Anthony MS, Zavras A, Calingaert B. Multiple myeloma and IV bisphosphonate are risk factors for osteonecrosis of the jaw. Poster presented at the 26th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(S1):S313-4.

Huang K, Gutierrez LP, Bulow S, Gallinger S, Castells A, Eagle CJ, Church JM. Clinical outcomes in familial adenomatous polyposis (FAP) patients with a long-term treatment of celecoxib: a matched cohort study. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(Suppl 1):S:61.

Gilsenan AW, Andrews EB, Midkiff KD, Ladner A. Charting a new course in long-term safety: the critical role of cancer registries. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(Suppl 1):S116.

Martín-Merino M, Fortuny J, Plana E, Rivero E, García-Rodríguez LA. Incidence of diabetic retinopathy and diabetic macular edema in newly diagnosed type I and type 2 diabetic patients. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(Suppl 1):S251-2.

López-León S, Fortuny J, Plana E, Rivero E. The pattern of use of anti-depressant drugs. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(1):S289.

Mines D. Invited editorial. Commentary on the validation studies of sudden cardiac death and ventricular arrhythmia by Hennessy et al. and Chung et al. Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):573-5. doi: 10.1002/pds.1913.

Varas-Lorenzo C, Castellsaque J, Stang MR, Perez-Gutthann S, Aguado J, Rodriguez LA. The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada. Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1016-25.

Andrews EB, Colvin L, Hernández-Díaz S, Holmes L, Chambers T, Margulis A, Mitchell A. Evaluating study designs for the measurement of drug exposure in pregnancy. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S28-9.

Riera-Guardia N, Hirst C, Castellsague J, Varas-Lorenzo C, Pariente A, Sturkenboom MCJM, Perez-Gutthann S. The SOS project: cardiovascular and gastrointestinal safety of NSAIDS. Preliminary results of a systematic review of epidemiological studies. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S207.

Acquavella J, Weinhandl E, Bradbury B, Brookhart A, Sturmer T, Rothman KJ. Confounding by indication studying epoetin and mortality. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S28.

Perez-Gutthann S, Sturmer T, Platt R, Strom BL, Saddier P, Raine J. How should we plan and communicate interim results of pharmacoepidemiology studies? An ispe public policy forum. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S123-4.

Saddier P, Perez-Gutthann S, Stem-hagen A, Garg R, Blackburn S, Dal Pan G. Rmp, riskmap and rems: the challenges of epidemiology. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S203-4.

Villa M, Mannino S, Lucchi S, Rothman KJ. Definition of the risk-window for the outcomes of the live study by minimization of the mean squared error (MSE) of the estimator. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S151.

Midkiff KD, Gilsenan AW, Martin RD, Wu Y, Masica D, Andrews EB. The impact of patient access on post marketing drug safety studies using cancer registry data. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 14; 18(Suppl 1):S169. doi: 10.1002/pds.1806

Loughlin J, Quinn S, Rivero E, Norman H, Earnest DL, Wong J, Seeger JD. No evidence for association of tegaserod with suicide-related outcomes. Poster presented at the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug; 18(Suppl 1):S154-5.

Loughlin J, Quinn S, Rivero E, Norman H, Earnes DL, Wong J, Seeger JD. No evidence for association of tegaserod with adverse cardiovascular ischemic events. Presented at the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug; 18(Suppl 1):S17.

Rothman KJ, Dal Pan G, Evans S, Stang P, Jones J, Sturmer T. The future of epidemiology. Presented at the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 16, 2009. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug; 18(Suppl 1):S205.

Arana A, Arellano FM, Rivero E, Wentworth CW, Fortuny J. Incidence of endophthalmitis after intravitreal injection procedures in the general population of the United States of America. Poster presented at the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug; 18(Suppl 1):S151-2.

Varas-Lorenzo C, Johannes C, McQuay L, Midkiff K, Stang MR, Fife D. Validation of serious ventricular arrhythmias in an administrative database. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 16, 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug; 18(S1-273):S222.

Habib ZA, Tzogias L, Havstad SL, Wells K, Divine G, Lanfear DE, Tang J, Krajenta R, Pladevall-Vila M, Williams LK. Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis. Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):437-47. doi: 10.1002/pds.1722

Varas-Lorenzo C, Castellsague J, Stang MR, Perez-Gutthann S, Aguado J, Rodriguez LA. The use of selective cycoxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada. Pharmacoepidemiol Drug Saf. 2009;18(11):1016-25.

Geier J, Juhaeri J, Mines D, Mosholder A, Trivedi M, Eng S, Skovron ML, Stang P, Volkova N. Assessing the association of pharmacotherapeutics and suicidal behavior: lessons from the front. Presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009; 18(S1):S125.

Rothman KJ, Suissa S. Exclusion of immortal person-time. Pharmacoepidemiol Drug Saf. 2008 Oct 1;17(10):1036.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Arana A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Pharmacoepidemiol Drug Saf. 2008 Oct 1;17(10):1037. doi: 10.1002/pds.1636

Cooper G, Mines D, Gu Y. Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study. Presented at the 24th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; 2008. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2008 Aug; 17(S1):S110-1.

Arana A, Arellano FM, Rivero E, Pavesi M, Dey D, Wentworth CW. Intravitreal (IVT) injection-related ocular adverse events in the general population of the United States of America. Poster presented at the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2008. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2008 Aug; 17(Suppl 1):S75-6.

Varas-Lorenzo C, Castellsague J, Stang MR, Tomas L, Aguado J, Perez-Gutthann S. Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database. Pharmacoepidemiol Drug Saf. 2008 Aug 1;17(8):842-52.

Varas-Lorenzo C, Castellsaque J, Stang MR, Tomas L, Aguado J, Perez-Gutthann S. Positive predictive value of icd-9 codes 410-411 for acute coronary syndromes: saskatchewan hospital automated database. Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):842-52.